{{Rsnum
|rsid=3118536
|Gene=RXRA
|Chromosome=9
|position=134416616
|Orientation=plus
|GMAF=0.1579
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=RXRA
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 0.9 | 26.8 | 72.3
| HCB | 5.8 | 32.8 | 61.3
| JPT | 4.5 | 29.5 | 66.1
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 17.5 | 82.5
| CHB | 5.8 | 32.8 | 61.3
| CHD | 4.6 | 33.0 | 62.4
| GIH | 5.9 | 42.6 | 51.5
| LWK | 0.0 | 0.0 | 0.0
| MEX | 5.2 | 36.2 | 58.6
| MKK | 0.0 | 2.6 | 97.4
| TSI | 4.9 | 33.3 | 61.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=20145122
|Title=Genetic Polymorphisms in Vitamin D Receptor VDR/RXRA Influence the Likelihood of Colon Adenoma Recurrence
|OA=1
}}

{{PMID|18254975|OA=1
}} Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat.

{{PMID|20049159|OA=1
}} Vitamin d pathway genes, diet, and risk of renal cell carcinoma.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}